USPTO serial 85161282
CATACLEAVE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- AIKENS, RONALD E
- Law office
- TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CATACLEAVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kyeongsangnam-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin G. Smith
KEVIN G. SMITH SUGHRUE MION, PLLC2100 PENNSYLVANIA AVE NWWASHINGTON, DC 20037-3202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents for non-medical purposes; biochemical catalysts; chemical preparations for analyses in laboratories other than for medical or veterinary use, namely, Lysis buffer, binding buffer, Proteinase K, Washing buffer and chemical reagents; diagnostic preparations other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary use; chemical reagents for nucleic acid diagnostics for non-medical purposes; reagent kits comprising Lysis buffer, binding buffer, Proteinase K, Washing buffer and chemical reagents for use in extracting nucleic acid for non-medical purposes; preparations of micro-organisms other than for medical and veterinary use; bacterial preparations other than for medical and veterinary use | ACTIVE | — |
| 005 | Diagnostic preparations for medical and veterinary purposes; chemical reagents for medical or veterinary purposes; diagnostic reagents for immune disease; reagents for clinical medical diagnostic laboratory tests; medical reagents for clinical diagnostics; reagents for measuring antibody; diagnostic reagents for blood testing; diagnostic reagents for blood analysis; diagnostic reagents for genes; diagnostic reagents; diagnostic reagents for nucleic acid; ferments for medical or veterinary use; medical reagents in DNA microarray; diagnostic reagents for infectious disease; diagnostic reagents for sexually transmitted disease; nucleic acid diagnostic reagents for detecting infectious disease; nucleic acid diagnostic reagents for detecting sexually transmitted disease; diagnostic reagents for food poisoning bacteria; diagnostic reagents for esherichia coli; nucleic acid diagnostic reagents for detecting food poisoning bacteria; nucleic acid diagnostic reagents for detecting esherichia coli; reagents for detecting sexually transmitted disease; reagents for detecting bacteria diseases; nucleic acid diagnostic reagents for detecting bacterial diseases; reagents for detecting viral diseases; nucleic acid diagnostic reagents for detecting viral diseases; reagents for testing of food safety for medical purposes; reagents for testing of food for medical purposes | ACTIVE | — |
| 009 | DNA chips; incubators for bacteria culture; automatic nucleic acid extractors; apparatus for analysis of liquids and reagents, namely, liquid chromatography apparatus; dispensers of liquids and reagents; automatic dispensers, namely, dispensers that count or measure output for use with laboratory liquids and reagents; gene amplifiers; laboratory analytical apparatus for use in medical laboratories, namely, nucleic acid extractor, PCR machine, Realtime-PCR machine, nucleic acid amplification machine, optical detector, isothermal amplification machine, microarray cartridge, microarray device, microfluidics cartridge, microfluidics device, DNA chip strip, DNA chip device and DNA sequencing machine; apparatus for gene analysis for detecting genetic sequences, namely, nucleic acid extractor, PCR machine, Realtime-PCR machine, nucleic acid amplification machine, optical detector, isothermal amplification machine, microarray cartridge, microarray device, microfluidics cartridge, microfluidics device, DNA chip strip, DNA chip device and DNA sequencing machine; DNA, RNA and gene decoding apparatus for nucleic acid microarray; nucleic acid amplifiers; apparatus for analyzing the concentration and purity of nucleic acid, namely, nucleic acid extractor, PCR machine, Realtime-PCR machine, optical detector, isothermal amplification machine, microarray cartridge, microarray device, microfluidics cartridge, microfluidics device, DNA chip strip, DNA chip device and DNA sequencing machine; apparatus for nucleic acid sequence analysis | ACTIVE | — |
| 010 | Diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for infectious disease; diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for sexually transmitted disease; detection kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for infectious disease; detection kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for sexually transmitted disease; nucleic acid diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for detecting infectious diseases; nucleic acid diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for detecting sexually transmitted disease; detection kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for food poisoning bacteria; detection kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for esherichia coli; nucleic acid diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for detecting food poisoning bacteria; medical aerosol dispensers for detecting infectious disease; nucleic acid extractors for detecting infectious disease; amplifiers, namely, PCR amplifier, isothermal amplifier and DNA/RNA amplifier for nucleic acid amplification for detecting infectious disease; medical aerosol dispensers for detecting food poisoning bacteria; nucleic acid extractors for detecting food poisoning bacteria; amplifiers, namely, PCR amplifier, isothermal amplifier and DNA/RNA amplifier for nucleic acid amplification for detecting food poisoning bacteria; diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for testing pestiferous infection; diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for testing virus infection; diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for testing microorganism infection; detection kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for bacterial diseases; nucleic acid diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for detecting for bacterial diseases; detection kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for viral diseases; nucleic acid diagnostic kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for detecting viral diseases; kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for food safety testing for medical purposes; kits comprising primarily of probes, primers, polymerases, dNTPs, Lysis buffer, binding buffer, Proteinase K, Washing buffer, buffers and reagents for food testing for medical purposes | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; medical research services in the field of cancer; research for medical products; medical research; research and development of DNA chips; structural and functional analysis of genomes; research in the biotechnology fields; advisory services in the field of biotechnology; biological research; biochemical analysis; biochemical research; inspection of foodstuff; research on food; rental of laboratory apparatus and instruments; research and development for new products for others; testing of seeds of others for the purpose of certification; chemical analysis; chemistry services, namely, consulting and advice in the field of medical-related chemistry; chemical research and analysis; research in the field of chemistry; food safety testing | ACTIVE | — |
| 044 | dispensing of pharmaceuticals; providing medical information via the internet, telecommunication networks, a website, and in person; clinical medicine, namely blood and tissue sample testing for the diagnosis of disease; performing diagnosis of diseases; rental of medical equipment; dispensing of nucleic acid diagnostic reagents for detecting infectious disease; performing diagnosis of infectious diseases; dispensing of nucleic acid diagnostic reagents for detecting food poisoning bacteria; performing diagnosis of food poisoning bacteria; dispensing of nucleic acid diagnostic reagents for detecting sexually transmitted disease; dispensing of nucleic acid diagnostic reagents for detecting bacterial diseases; dispensing of nucleic acid diagnostic reagents for detecting viral diseases; dispensing of nucleic acid diagnostic reagents for testing of food safety; diagnostic services in the field of sexually transmitted disease; diagnostic services in the field of bacterial diseases; diagnostic services in the field of viral diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SAMSUNG TECHWIN CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CATACLEAVE
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 22, 2012 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 22, 2012 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 25, 2012 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 25, 2012 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 25, 2012 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 19, 2012 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 19, 2012 | ALIE | ASSIGNED TO LIE | — |
| Sep 18, 2011 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 18, 2011 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 18, 2011 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 28, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2010 | NWAP | NEW APPLICATION ENTERED | — |